These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Mitochondrial Replacement Therapy: Unmade in the USA. Adashi EY; Cohen IG JAMA; 2017 Feb; 317(6):574-575. PubMed ID: 28196242 [No Abstract] [Full Text] [Related]
10. [Mitochondrial replacement--potential therapy method with ethical implications. Severe disease may be prevented, but knowledge gaps exist]. Ramsay KW; Hanson C; Asplund K Lakartidningen; 2014 Jul 16-Aug 5; 111(29-31):1240-3. PubMed ID: 25180425 [No Abstract] [Full Text] [Related]
11. Clinical and ethical implications of mitochondrial gene transfer. Mitalipov S; Wolf DP Trends Endocrinol Metab; 2014 Jan; 25(1):5-7. PubMed ID: 24373414 [TBL] [Abstract][Full Text] [Related]
12. Gene Editing: A View Through the Prism of Inherited Metabolic Disorders. Davison J New Bioeth; 2018 Apr; 24(1):2-8. PubMed ID: 29529978 [TBL] [Abstract][Full Text] [Related]
13. SCIENCE AND REGULATION. The FDA is prohibited from going germline. Cohen IG; Adashi EY Science; 2016 Aug; 353(6299):545-6. PubMed ID: 27493171 [No Abstract] [Full Text] [Related]
14. The pedagogical significance of the Bush stem cell policy: a window into bioethical regulation in the United States. Snead OC Yale J Health Policy Law Ethics; 2005; 5(1):491-504. PubMed ID: 15742591 [No Abstract] [Full Text] [Related]